Needham Reiterates Buy Rating on AtriCure Inc. (ATRC)
Tweet Send to a Friend
Needham analyst Mike Matson reiterated a Buy rating and $45.00 price target on AtriCure Inc. (NASDAQ: ATRC).The analyst commented: "Edwards ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
